IGF-1 LR3 Research and DEXA Scan Notes: What Wholesale Buyers Should Know

In research literature, "DEXA scan notes" are methodology records — the written detail describing how a dual-energy X-ray absorptiometry instrument produced a body-composition measurement within a study. They document the equipment, the calibration, the positioning and the timing behind a number. They are not usage guidance, and they say nothing about the quality of any compound sitting in a vial. For a business buyer sourcing IGF-1 LR3 or any other growth-factor-category research material, the useful lesson is procedural rather than clinical: the documentation standard that makes a measurement defensible is the same standard that makes a certificate of analysis defensible. Every compound discussed here is research use only and is not an FDA-approved drug.

What a dual-energy absorptiometry note actually records

The instrument works by passing X-rays at two distinct photon energies through a target and measuring how much of each is attenuated. Because bone mineral, lean soft tissue and fat attenuate the two energies in different proportions, the software can decompose each pixel into estimated tissue compartments and sum them across defined regions. That is the entire mechanism — a model fitted to attenuation ratios, not a direct weighing of tissue.

That mechanism is why the accompanying notes matter so much. A credible scan record generally captures the manufacturer, model and software version of the instrument; the calibration and phantom scan performed before the session; the scan mode selected; the positioning protocol and the exact boundaries used to define each region of interest; who operated the device; and the timing and state of the subject at acquisition. Change the software version and the derived compartment values can shift. Move a region boundary a few centimetres and the lean-mass figure moves with it. Run the scan at a different time of day, under different hydration conditions, and the soft-tissue estimate drifts.

Researchers handle this with precision testing — repeat scans used to establish how much change at a given site is distinguishable from measurement noise. Without that context, a reported difference is uninterpretable. This is also why figures from two different studies, on two different instruments, with two different region definitions, should not be stacked against each other as though they were the same measurement.

If you take one idea from scan methodology into your purchasing process, take this: a number without its method is not data. It is a claim. The same is true of a purity percentage printed on a supplier's website with no lot, no method and no date attached.

Why this compound appears alongside composition endpoints

IGF-1 LR3, or Long R3 IGF-1, is a structural analog of insulin-like growth factor 1. It carries an arginine substitution at position 3 and a thirteen-amino-acid extension at the N-terminus. Those modifications reduce its affinity for the insulin-like growth factor binding proteins that normally sequester native IGF-1 in circulation and in culture media. That property is the reason the analog became a common supplement in cell-culture and bioprocess work, where a signaling molecule that remains available rather than being bound up is operationally convenient.

Research suggests the IGF axis participates broadly in tissue growth, repair and metabolic signaling, which is why preclinical studies examining that axis often include body-composition endpoints — and why absorptiometry turns up in the methods sections. Studies indicate that the relationships involved are complex and species-dependent, and a large share of the published work is in vitro or in animal models. Extrapolating any of it is not something a supplier, a reseller or a catalog page should be doing on a buyer's behalf.

For a wholesale buyer, the relevant question is narrower and more answerable: can the material you are stocking be identified, quantified and traced to a batch? That question has a documentary answer. The biology does not.

Measurement notes and supply documents side by side

The parallel between a methods section and a supply-chain record is close enough to be useful as a checklist. Each row below pairs a research-documentation habit with its sourcing equivalent.

A supplier who can answer every cell in the right-hand column is running a documented operation. A supplier who answers two of six is asking you to take purity on faith.

Reading a certificate of analysis like a methods section

Identity and purity are different questions and they are established by different techniques. Purity by high-performance liquid chromatography is typically reported as an area percentage — the proportion of the chromatogram attributable to the main peak. That tells you how much of what was injected is one dominant species. It does not, on its own, confirm which species. Identity confirmation generally comes from mass spectrometry comparing the observed mass against the theoretical mass of the sequence. A COA showing purity without identity has answered half the question.

From there, the questions get practical:

• Is it lot-specific? A "representative" or "typical" COA describes something other than what you received. The lot on the document should match the lot on the vial.
• Is the chromatogram attached? A number in a table is a transcription. A chromatogram is evidence, and it shows peak shape, baseline and anything eluting nearby.
• Is the issuing lab named and dated? Undated results with no issuing party are not verifiable by anyone.
• Who paid for and controls the testing? Independent third-party testing and in-house testing are both legitimate, but the reader should know which one they are looking at.
• Does the COA cost extra? Some operators gate lab results behind a purchase, a login, or a fee. Verification you have to buy is a pricing decision dressed as a quality program.

Those last two points are where industry practice varies most. Hidden pricing, results released only on request, and testing described in marketing language without a method attached are all patterns worth pricing into your risk assessment before you commit to inventory.

Pricing tiers, minimums and fulfillment mechanics

Wholesale pricing in this category is structured rather than fixed, and the structure is where your real cost lives. Ask whether volume breaks are calculated per SKU or across a mixed order — the difference determines whether you can diversify a catalog or must concentrate spend to reach a tier. Ask whether tier assignment persists between orders or resets each time. Ask whether minimums are expressed in units, in dollars, or both.

Ask, too, about lot continuity. If you are stocking a SKU on a recurring basis, consistent sourcing and consistent testing across reorders matters more than a single good COA at the start. And ask how fulfillment actually runs: where orders ship from, what the handling window looks like, how backorders are communicated, and what happens to a shipment that arrives damaged.

Margin and markup figures quoted in this category should be treated with suspicion unless they come from your own books. Outcomes vary widely with volume, category, handling costs and the market you serve, and no supplier can responsibly forecast them for you.

Compliance questions that belong with your counsel

This section is informational and is not legal advice. The regulatory picture for research-use-only materials involves federal and state layers, and it can differ by business model, by the nature of your entity, and by how you describe what you sell. Rather than looking for a rule that permits or forbids an activity, bring these questions to your attorney and, where applicable, your state board:

• How should research-use-only labeling and marketing language be handled in your jurisdiction and for your entity type?
• Who is permitted to purchase, hold, relabel or resell these materials under your license or business registration?
• What recordkeeping, lot-traceability and storage documentation should your operation maintain?
• How do advertising and claim-substantiation rules apply to any description you publish?

And a plain boundary worth restating: questions about anything involving a living subject are not supplier questions. They belong with the appropriate licensed professional — a physician for human matters, a veterinarian for animal ones — alongside your counsel. A wholesale supplier's responsibility stops at identity, purity, traceability and delivery.

What Real Peptides does differently

Real Peptides operates its Wholesale Partner Program around documentation that a buyer can check independently. Compounds are produced to 99%+ HPLC purity. Every batch goes through 7-panel batch testing. COAs are publicly verifiable, meaning a prospective partner can review lab results directly rather than requesting them through a sales conversation or paying for access. Fulfillment is handled in the US with orders shipping within 5–7 days. Onboarding runs through a 3-step wholesale application rather than an open-ended negotiation.

Those are descriptive facts about how the program runs, and they are stated here as facts precisely because they are checkable. Purity figures, panel counts and COA access are the parts of a supplier relationship that should never require trust — they should require a link. All catalog items remain research use only.

If your operation is building a growth-factor or tissue-signaling shelf and you want documentation you can verify before the first purchase order, the Wholesale Partner Program application is the next step. It is short, it is the same process for every applicant, and it ends with access to tier pricing and lot-level lab records rather than a quote you have to chase.

For further reading, the Growth Factor & Tissue Signaling Research collection covers the compound category this article sits closest to, while adjacent catalog pages for CJC-1295 No DAC 10mg, Ipamorelin 10mg and Tesamorelin 10mg show the documentation format applied at the SKU level; buyers assembling a broader catalog often start from Popular Peptides or the Performance & Recovery Research collection.